Income Statement
Balance Sheet
Cash Flow
| Line Item | FY 2025Apr 30, 2025 | FY 2024Apr 30, 2024 | FY 2023Apr 30, 2023 | FY 2022Apr 30, 2022 | FY 2021Apr 30, 2021 |
|---|---|---|---|---|---|
| Total Revenue | 0.00 | 0.00 | 0.00 | 0.00 | -- |
| Operating Revenue | 0.00 | 0.00 | 0.00 | 0.00 | -- |
| Cost Of Revenue | 40,815 | 3,840 | 9,927 | 0.00 | -- |
| Gross Profit | -40,815 | -3,840 | -9,927 | 0.00 | -- |
| Selling General And Administration | 2.5M | 2.0M | 1.8M | 4.7M | -- |
| General And Administrative Expense | 2.5M | 2.0M | 1.8M | 4.7M | -- |
| Research And Development | 0.00 | 28,620 | 80,000 | -- | -- |
| Depreciation And Amortization In Income Statement | 3,498 | 3,498 | 2,245 | 0.00 | -- |
| Other Operating Expenses | 41,831 | 208,469 | 181,252 | 403,698 | -- |
| Operating Expense | 2.6M | 2.2M | 2.1M | 5.1M | -- |
| Operating Income | -2.6M | -2.2M | -2.1M | -5.1M | -- |
| EBIT | 7.5M | -2.4M | 12.4M | -5.0M | -- |
| Interest Expense | 14,101 | 19,910 | 1,473 | 3,783 | -- |
| Interest Expense Non Operating | 14,101 | 19,910 | 1,473 | 3,783 | -- |
| Interest Income | 2.1M | 2.6M | 1.1M | 0.00 | -- |
| Interest Income Non Operating | 2.1M | 2.6M | 1.1M | 0.00 | -- |
| Net Interest Income | 2.1M | 2.5M | 1.1M | -3,783 | -- |
| Other Income Expense | 7.9M | -2.7M | 13.4M | 70,432 | -- |
| Special Income Charges | -117,260 | -301,697 | 11.0M | 393,656 | -- |
| Gain On Sale Of Security | 8.3M | -1.5M | 2.7M | -323,224 | -- |
| Earnings From Equity Interest | -227,313 | -918,967 | -283,308 | 0.00 | -- |
| Pretax Income | 7.5M | -2.4M | 12.4M | -5.0M | -- |
| Tax Provision | 476,000 | -3.7M | 7.1M | -717,073 | -- |
| Tax Effect Of Unusual Items | 520,737 | -273,535 | 5.5M | 10,007 | -- |
| Net Income From Continuing And Discontinued Operation | 7.0M | 1.2M | 5.4M | -4.3M | -- |
| Net Income From Continuing Operation Net Minority Interest | 7.0M | 1.2M | 5.4M | -4.3M | -- |
| Net Income Including Noncontrolling Interests | 7.0M | 1.2M | 5.4M | -4.3M | -- |
| Minority Interests | -- | -- | 0.00 | 1,252 | -671.00 |
| Net Income Common Stockholders | 7.0M | 1.2M | 5.4M | -4.3M | -- |
| Net Income | 7.0M | 1.2M | 5.4M | -4.3M | -- |
| EBITDA | 7.5M | -2.4M | 12.4M | -5.0M | -- |
| Normalized EBITDA | -684,765 | -586,978 | -1.3M | -5.1M | -- |
| Reconciled Depreciation | 3,498 | 3,498 | 2,245 | 0.00 | -- |
| Basic EPS | -- | 0.01 | 0.03 | -0.02 | 0.11 |
| Diluted EPS | -- | 0.01 | 0.03 | -0.02 | 0.11 |
| Basic Average Shares | -- | 199.6M | 176.5M | 175.8M | 161.6M |
| Diluted Average Shares | -- | 199.6M | 176.5M | 175.8M | 164.5M |
| Total Unusual Items | 8.2M | -1.8M | 13.7M | 70,432 | -- |
| Total Unusual Items Excluding Goodwill | 8.2M | -1.8M | 13.7M | 70,432 | -- |
| Tax Rate For Calcs | 0.06 | 0.15 | 0.40 | 0.14 | -- |
| Normalized Income | -657,627 | 2.8M | -2.8M | -4.4M | -- |
| Amortization | 3,498 | 3,498 | 2,245 | 0.00 | -- |
| Amortization Of Intangibles Income Statement | 3,498 | 3,498 | 2,245 | 0.00 | -- |
| Depreciation Amortization Depletion Income Statement | 3,498 | 3,498 | 2,245 | 0.00 | -- |
| Diluted NI Availto Com Stockholders | 7.0M | 1.2M | 5.4M | -4.3M | -- |
| Gain On Sale Of Business | 109,970 | 885,467 | 429,696 | 0.00 | -- |
| Gain On Sale Of Ppe | -- | 0.00 | 11.0M | 1.1M | 0.00 |
| Impairment Of Capital Assets | 227,230 | 1.2M | 359,842 | 667,195 | -- |
| Insurance And Claims | 33,103 | 30,280 | 28,375 | 42,702 | -- |
| Net Income Continuous Operations | 7.0M | 1.2M | 5.4M | -4.3M | -- |
| Net Non Operating Interest Income Expense | 2.1M | 2.5M | 1.1M | -3,783 | -- |
| Other Gand A | 1.8M | 1.8M | 1.5M | 2.7M | -- |
| Reconciled Cost Of Revenue | 40,815 | 3,840 | 9,927 | 0.00 | -- |
| Rent And Landing Fees | 30,606 | 41,636 | 62,056 | 345,232 | -- |
| Rent Expense Supplemental | 30,606 | 41,636 | 62,056 | 345,232 | -- |
| Salaries And Wages | 650,481 | 133,746 | 153,538 | 1.6M | -- |
| Selling And Marketing Expense | 7,545 | 4,780 | 18,706 | 13,336 | -- |
| Total Expenses | 2.6M | 2.2M | 2.1M | 5.1M | -- |
| Total Operating Income As Reported | -2.6M | -2.2M | -2.1M | -5.1M | -- |
| Line Item | FY 2025Apr 30, 2025 | FY 2024Apr 30, 2024 | FY 2023Apr 30, 2023 | FY 2022Apr 30, 2022 | FY 2021Apr 30, 2021 |
|---|---|---|---|---|---|
| Cash And Cash Equivalents | 415,920 | 564,117 | 2.4M | 5.5M | -- |
| Cash Cash Equivalents And Short Term Investments | 26.0M | 24.3M | 24.3M | 28.3M | -- |
| Cash Financial | 415,920 | 564,117 | 2.4M | 5.5M | -- |
| Other Short Term Investments | 25.6M | 23.7M | 22.0M | 22.8M | -- |
| Accounts Receivable | -- | -- | -- | -- | 0.00 |
| Receivables | 405,194 | 879,926 | 328,529 | 169,217 | -- |
| Prepaid Assets | 54,861 | 80,856 | 261,924 | 81,820 | -- |
| Current Assets | 26.5M | 25.2M | 24.9M | 28.5M | -- |
| Gross PPE | -- | -- | 6.6M | 13.2M | 13.3M |
| Net PPE | 5.9M | 6.2M | 6.6M | 13.2M | -- |
| Investments And Advances | 4.1M | 4.1M | 3.1M | 0.00 | -- |
| Long Term Equity Investment | 4.1M | 4.1M | 3.1M | 0.00 | -- |
| Total Non Current Assets | 37.7M | 30.1M | 28.7M | 13.2M | -- |
| Total Assets | 64.1M | 55.3M | 53.7M | 41.7M | -- |
| Accounts Payable | 806,452 | 263,601 | 242,546 | 300,598 | -- |
| Payables | 7.3M | 6.5M | 6.9M | 706,788 | -- |
| Payables And Accrued Expenses | 7.3M | 6.5M | 6.9M | 706,788 | -- |
| Current Deferred Revenue | -- | -- | 0.00 | 144,187 | 144,187 |
| Other Current Liabilities | -- | -- | -- | -- | 200,000 |
| Current Liabilities | 7.3M | 6.5M | 6.9M | 850,975 | -- |
| Total Non Current Liabilities Net Minority Interest | 931,179 | 455,179 | 4.1M | 3.6M | -- |
| Total Liabilities Net Minority Interest | 8.3M | 6.9M | 11.0M | 4.5M | -- |
| Common Stock | 46.0M | 46.0M | 41.6M | 41.6M | -- |
| Capital Stock | 46.0M | 46.0M | 41.6M | 41.6M | -- |
| Additional Paid In Capital | 15.0M | 14.5M | 14.5M | 14.5M | -- |
| Retained Earnings | -5.2M | -12.2M | -13.4M | -18.8M | -- |
| Common Stock Equity | 55.9M | 48.4M | 42.7M | 37.3M | -- |
| Stockholders Equity | 55.9M | 48.4M | 42.7M | 37.3M | -- |
| Total Equity Gross Minority Interest | 55.9M | 48.4M | 42.7M | 37.2M | -- |
| Minority Interest | -- | 0.00 | 0.00 | -93,270 | -92,018 |
| Total Capitalization | 55.9M | 48.4M | 42.7M | 37.3M | -- |
| Net Tangible Assets | 55.9M | 48.4M | 42.7M | 37.3M | -- |
| Tangible Book Value | 55.9M | 48.4M | 42.7M | 37.3M | -- |
| Working Capital | 19.1M | 18.8M | 18.0M | 27.7M | -- |
| Invested Capital | 55.9M | 48.4M | 42.7M | 37.3M | -- |
| Share Issued | 240.9M | 240.9M | 176.5M | 176.5M | -- |
| Ordinary Shares Number | 240.9M | 240.9M | 176.5M | 176.5M | -- |
| Accrued Interest Receivable | 345,960 | 345,945 | 0.00 | -- | -- |
| Current Deferred Liabilities | -- | -- | 0.00 | 144,187 | 144,187 |
| Dueto Related Parties Current | 466,691 | 141,425 | 18,401 | 406,190 | -- |
| Income Tax Payable | 6.1M | 6.1M | 6.7M | 0.00 | -- |
| Investmentsin Associatesat Cost | 4.1M | 4.1M | 3.1M | 0.00 | -- |
| Non Current Deferred Liabilities | 931,179 | 455,179 | 4.1M | 3.6M | -- |
| Non Current Deferred Taxes Liabilities | 476,000 | 0.00 | 3.7M | 3.3M | -- |
| Non Current Note Receivables | 27.6M | 19.8M | 19.1M | 0.00 | -- |
| Other Properties | -- | -- | 6.6M | 13.2M | 13.3M |
| Other Receivables | -- | 49,009 | 49,237 | 5,579 | 9,213 |
| Receivables Adjustments Allowances | -- | -- | -- | -- | 0.00 |
| Taxes Receivable | 59,234 | 484,972 | 279,292 | 163,638 | -- |
| Total Tax Payable | 6.1M | 6.1M | 6.7M | 0.00 | -- |
| Line Item | FY 2025Apr 30, 2025 | FY 2024Apr 30, 2024 | FY 2023Apr 30, 2023 | FY 2022Apr 30, 2022 | FY 2021Apr 30, 2021 |
|---|---|---|---|---|---|
| Operating Cash Flow | -142,116 | -2.2M | -1.6M | -3.8M | -- |
| Cash Flow From Continuing Operating Activities | -46,906 | -2.2M | -1.6M | -3.8M | -- |
| Depreciation And Amortization | 3,498 | 3,498 | 2,245 | 0.00 | -- |
| Depreciation Amortization Depletion | 3,498 | 3,498 | 2,245 | 0.00 | -- |
| Stock Based Compensation | 488,485 | 0.00 | 24,467 | 1.3M | -- |
| Deferred Tax | 476,000 | -3.7M | 7.1M | -717,073 | -- |
| Deferred Income Tax | 476,000 | -3.7M | 7.1M | -717,073 | -- |
| Change In Working Capital | 1.4M | -634,242 | -198,549 | -266,959 | -- |
| Changes In Account Receivables | -- | 831.00 | -781.00 | 0.00 | -- |
| Change In Receivables | 469,061 | -156,372 | -159,312 | -80,746 | -- |
| Change In Payables And Accrued Expense | 868,118 | -463,938 | -54,133 | -244,992 | -- |
| Change In Payable | 868,118 | -463,938 | -54,133 | -244,992 | -- |
| Other Non Cash Items | -2.2M | -2.4M | -1.1M | -1.1M | -- |
| Capital Expenditure | -492,218 | -751,608 | -600,870 | -1.2M | -- |
| Purchase Of PPE | -492,218 | -751,608 | -600,870 | -1.2M | -- |
| Net PPE Purchase And Sale | -492,218 | -751,608 | -550,870 | 184,714 | -- |
| Purchase Of Business | -170,252 | -876,350 | -325,000 | 0.00 | -- |
| Purchase Of Investment | -- | -2.4M | -3.5M | -2.4M | 0.00 |
| Sale Of Investment | -- | 4,000 | 2.9M | 0.00 | 11.2M |
| Net Investment Purchase And Sale | 636,389 | -2.4M | -640,430 | -2.4M | -- |
| Investing Cash Flow | -26,081 | -4.0M | -1.5M | -2.3M | -- |
| Cash Flow From Continuing Investing Activities | -26,081 | -4.0M | -1.5M | -2.3M | -- |
| Issuance Of Capital Stock | 0.00 | 4.4M | 0.00 | 1.1M | -- |
| Net Common Stock Issuance | 0.00 | 4.4M | 0.00 | 1.1M | -- |
| Financing Cash Flow | 20,000 | 4.4M | 0.00 | 1.1M | -- |
| Cash Flow From Continuing Financing Activities | 20,000 | 4.4M | 0.00 | 1.1M | -- |
| Changes In Cash | -148,197 | -1.8M | -3.1M | -4.9M | -- |
| Beginning Cash Position | 564,117 | 2.4M | 5.5M | 10.4M | -- |
| End Cash Position | 415,920 | 564,116 | 2.4M | 5.5M | -- |
| Free Cash Flow | -634,334 | -3.0M | -2.2M | -4.9M | -- |
| Asset Impairment Charge | 227,230 | 1.2M | 359,842 | 708,238 | -- |
| Change In Account Payable | 542,853 | 21,055 | -58,052 | -217,643 | -- |
| Change In Income Tax Payable | 0.00 | -608,017 | 0.00 | -- | -- |
| Change In Prepaid Assets | 25,995 | -13,932 | 14,896 | 58,779 | -- |
| Change In Tax Payable | 0.00 | -608,017 | 0.00 | -- | -- |
| Common Stock Issuance | 0.00 | 4.4M | 0.00 | 1.1M | -- |
| Earnings Losses From Equity Investments | 227,313 | 918,967 | 283,308 | -- | -- |
| Gain Loss On Investment Securities | -- | 1,000 | -313,740 | -- | -6.8M |
| Gain Loss On Sale Of Business | -109,970 | -885,467 | -429,696 | 0.00 | -- |
| Gain Loss On Sale Of PPE | -- | 0.00 | -11.0M | -1.1M | -- |
| Net Business Purchase And Sale | -170,252 | -876,350 | -325,000 | 0.00 | -- |
| Net Income From Continuing Operations | 7.0M | 1.2M | 5.4M | -4.3M | -- |
| Net Other Financing Charges | 20,000 | -- | -- | 1.3M | -- |
| Net Other Investing Changes | -- | -- | -- | -- | -950,000 |
| Operating Gains Losses | 119,449 | 34,500 | -11.4M | -1.1M | -- |
| Sale Of PPE | -- | 50,000 | 50,000 | 1.3M | 0.00 |
| Unrealized Gain Loss On Investment Securities | -7.7M | 2.1M | -1.7M | 633,224 | -- |